Search

Results 1-10 of 27
Publication DateTitleAuthor(s)
24-Mar-2017Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is down-regulated in metaplastic breast cancerYague, E; Asaduzzaman, M; Constantinou, S; Haoxiang, M; Gallon, J, et al
24-Sep-2015APOBEC3B mediated cytidine deamination is required for estrogen receptor action in breast cancerAli, S; Periyasamy, M; Patel, H; Lai, C-F; Nguyen, VTM, et al
21-Jan-2014Engineered repressors are potent inhibitors of androgen receptor activityBrooke, GN; Powell, SM; Lavery, DN; Waxman, J; Buluwela, L, et al
14-Jun-2016CDK7, cyclin H and MAT1 is elevated in breast cancer and is prognostic in estrogen receptor- positive breast cancerPatel, H; Abduljabbar, R; Lai, CF; Periyasamy, M; Harrod, A, et al
27-Nov-2015Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasionNguyen, VTM; Barozzi, I; Faronato, M; Lombardo, Y; Steel, JH, et al
1-Oct-2013Critical research gaps and translational priorities for the successful prevention and treatment of breast cancerEccles, SA; Aboagye, EO; Ali, S; Anderson, AS; Armes, J, et al
19-Jan-2012Differential oestrogen receptor binding is associated with clinical outcome in breast cancerRoss-Innes, CS; Stark, R; Teschendorff, AE; Holmes, KA; Ali, HR, et al
1-Jan-2005T : G mismatch-specific thymine-DNA glycosylase (TDG) as a coregulator of transcription interacts with SRC1 family members through a novel tyrosine repeat motifLucey, MJ; Chen, DS; Lopez-Garcia, J; Hart, SM; Phoenix, F, et al
23-Feb-2004Tumour necrosis factor and PI3-kinase control oestrogen receptor alpha protein level and its transrepression functionBhat-Nakshatri, P; Campbell, RA; Patel, NM; Newton, TR; King, AJ, et al
3-Nov-2006ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylasesLopez-Garcia, J; Periyasamy, M; Thomas, RS; Christian, M; Leao, M, et al